期刊
MOLECULAR ONCOLOGY
卷 11, 期 10, 页码 1307-1329出版社
WILEY
DOI: 10.1002/1878-0261.12075
关键词
cancer; cancer-associated fibroblast; kallikrein-related peptidase; KLK; prostate cancer; tumour microenvironment
类别
资金
- National Health and Medical Research Council [1010141, 1091734, 1035721, 1102752, 1005717]
- Prostate Cancer Foundation of Australia [YI0715]
- Movember (Movember Revolutionary Team Award) [YI0911]
- Cancer Council Queensland [1064484, 1084224]
- ARC [FT120100917]
- National Health and Medical Research Council of Australia [614296]
- Prostate Cancer Foundation Australia
- QUT Postgraduate Scholarship
- Australian Research Council [FT120100917] Funding Source: Australian Research Council
- National Health and Medical Research Council of Australia [1102752, 1091734] Funding Source: NHMRC
The reciprocal communication between cancer cells and their microenvironment is critical in cancer progression. Although involvement of cancerassociated fibroblasts (CAF) in cancer progression is long established, the molecular mechanisms leading to differentiation of CAFs from normal fibroblasts are poorly understood. Here, we report that kallikrein-related peptidase-4 (KLK4) promotes CAF differentiation. KLK4 is highly expressed in prostate epithelial cells of premalignant (prostatic intraepithelial neoplasia) and malignant lesions compared to normal prostate epithelia, especially at the peristromal interface. KLK4 induced CAF-like features in the prostate-derived WPMY1 normal stromal cell line, including increased expression of alpha-smooth muscle actin, ESR1 and SFRP1. KLK4 activated protease-activated receptor-1 in WPMY1 cells increasing expression of several factors (FGF1, TAGLN, LOX, IL8, VEGFA) involved in prostate cancer progression. In addition, KLK4 induced WPMY1 cell proliferation and secretome changes, which in turn stimulated HUVEC cell proliferation that could be blocked by a VEGFA antibody. Importantly, the genes dysregulated by KLK4 treatment of WPMY1 cells were also differentially expressed between patient-derived CAFs compared to matched nonmalignant fibroblasts and were further increased by KLK4 treatment. Taken together, we propose that epithelial-derived KLK4 promotes tumour progression by actively promoting CAF differentiation in the prostate stromal microenvironment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据